A Multicenter Phase III Clinical Study and Translational Research on Adaptive Neoadjuvant Therapy of De-escalation and Escalation for HER2-Positive Breast Cancer Based on Multi-Omics Response Evaluation Model
Clinical trial NCT07239271 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07239271
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-16
- Primary completion
- 2027-12-01
- Enrollment
- 2000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.